105
Participants
Start Date
August 31, 2012
Primary Completion Date
December 31, 2013
Study Completion Date
December 31, 2013
Drug: 99mTc-MIP-1404
A single dose of 20 ±3 mCi intravenous (IV) injection of 99mTc-MIP-1404
University Hospitals Leuven, Leuven
Bajcsy-Zsilinszky Hospital, Department of Urology, Budapest
New York Presbyterian Hospital - Cornell, New York
University of Turin, Torino
University Hospital Motol, Clinic of Urology, Prague
Thomas Jefferson University / Jefferson Urology Associates, Philadelphia
Vita-Salute University San Raffaele, Milan
Duke University Medical Center, Durham
Medical University of South Carolina, Charleston
University Hospital Plzen, Department of Urology, Pilsen
Glickman Urology & Kidney Institute, Cleveland Clinic, Cleveland
4th Military Teaching Hospital and Polyclinic,, Wroclaw
"Provincial Specialist Hospital in Wroclaw, Department of Urology", Wroclaw
University of Wisconsin, Madison
Mayo Clinic, Rochester
University of Texas Vanguard Urologic Research Foundation, Houston
University Clinical Centre, Department of Urology, Gdansk
City of Hope National Cancer Center, Duarte
University of Washington School of Medicine, Seattle
City Clinical Hospital # 57, Moscow
"Federal Public State Institution Russian Oncology Research Center n.a. N.N. Blokhin under the Russian Academy of medical sciences", Moscow
Moscow Oncology Research Institute n.a. P.A. Hertsen, Moscow
All-Russia Centre for Urgent Care and Radiation Medicine named after A.M. Nikiforov under the Ministry of the Russian Federation for Civil Defence, Emergencies and Elimination of Consequences of Natural Disasters, Saint Petersburg
Federal State Public Institution Russian Research center for Radiology and Surgical Technologies under the Federal agency for High-tech medical care, Saint Petersburg
Research Institute of Oncology n.a. Professor N.N. Petrov under the Federal Agency for Healthcare and Social Development, Saint Petersburg
"St. Petersburg State Public Medical Institution: Clinical Oncological Center", Saint Petersburg
"Federal State Public Institution Medical Radiology Research Center of Healthcare Ministry and Social Development of Russian Federation", Obninsk
University Hospital Olomouc, Clinic of Urology, Olomouc
General University Hospital in Prague, Clinic of Urology, Prague
Thomayer's Hospital, Prague
Hospital Na Bulovce, Department of Urology, Prague
Peterfy Sandor Street Hospital, Department of Urology, Budapest
Jahn Ferenc South Pest Hospital, Department of Urology, Budapest
UMC St. Radboud Nijmegen, Nijmegen
University Hospital Plzen, Department of Urology, Warsaw
Lead Sponsor
Molecular Insight Pharmaceuticals, Inc.
INDUSTRY